A staggering 50% of Americans are grappling with prediabetes or diabetes, particularly among those over 65. The rise of non-alcoholic fatty liver disease is alarming, as it shares risk factors with type 2 diabetes and is poised to become the leading cause of liver transplants. With cardiovascular disease as the top killer in the U.S., understanding these interconnected metabolic issues is crucial for public health.
